The DOI matches its OpenAlex record; 39 of the 39 references it cites were found in a registry or an index.
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Abstract
BACKGROUND: Audits of heparin sodium therapy suggest that heparin administration is fraught with difficulty. The literature indicates that the current clinical practice of intuitive ordering of heparin results in inadequate therapy because of fear of bleeding. The importance of exceeding the lower limit of the therapeutic range has been strongly supported by findings of prospective clinical trials. Firm evidence indicates that failure to exceed the lower limit is associated with unacceptably high rates of recurrent venous thromboembolism. By comparison, evidence supporting the risk of exceeding the upper limit of the therapeutic range is weak. OBJECTIVES: The purposes of this study were (1) to validate prospectively an approach designed to minimize the proportion of patients receiving subtherapeutic doses of heparin and (2) to determine the effectiveness and safety of decreasing the heparin dosage infused on the basis of activated partial thromboplastin time (APTT) prolongation reflecting both heparin and warfarin sodium effects. METHODS: We performed a randomized double-blind study evaluating a prescriptive approach to heparin administration in patients receiving heparin or heparin with warfarin. Thromboembolic and bleeding complications were objectively documented. RESULTS: Only 1% and 2% of patients had subtherapeutic heparin levels for 24 hours or more in the heparin and combined groups, respectively. Recurrent venous thromboembolism occurred infrequently in both groups (7%). Sixty-nine (69%) of 99 patients receiving combined therapy had supratherapeutic values, compared with 24 (24%) of 100 receiving heparin; bleeding complications occurred in 9% and 12%, respectively. CONCLUSIONS: Our findings demonstrate that no association exists between supratherapeutic APTT responses and bleeding, which is in direct contrast to the observed association between subtherapeutic APTT responses and recurrent venous thromboembolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationWeitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Roentgen Diagnosis of Venous Thrombosis in the Leg
Rabinov, K. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 740
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Self-citationHull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
Self-citationThe Box Plot: A Simple Visual Method to Interpret Data
Williamson, D. F., Parker, R. A., & Kendrick, J. S. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-11-916 · Cited by 702
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Self-citationBasu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Genton, E., Hirsh, J., Gent, M., Sackett, D., McLoughlin, D., & Armstrong, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910183011602 · Cited by 604
Self-citationPrandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Self-citationAdjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G., & McLaughlin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201283060401 · Cited by 436
Self-citationManagement of Heparin Therapy: Controlled Prospective Trial
Salzman, E. W., Deykin, D., Shapiro, R. M., & Rosenberg, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505152922002 · Cited by 435
Hogg, P. J., & Jackson, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3619 · Cited by 347
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Heparin kinetics in venous thrombosis and pulmonary embolism.
Hirsh, J., van Aken, W. G., Gallus, A. S., Dollery, C. T., Cade, J. F., & Yung, W. L. (1976) · Circulation · doi:10.1161/01.cir.53.4.691 · Cited by 277
A standard heparin nomogram for the management of heparin therapy
Cruickshank, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.2.333 · Cited by 266
HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
Mant, M., Thong, K. L., Birtwhistle, R., O'Brien, B., Hammond, G., & Grace, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92388-1 · Cited by 242
Efficacy and Toxicity of Heparin in Relation to Age and Sex
Jick, H., Slone, D., Borda, I. T., & Shapiro, S. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808082790603 · Cited by 220
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.
Hull, R. D., Carter, C. J., Jay, R. M., Ockelford, P. A., Hirsch, J., Turpie, A. G., Zielinsky, A., Gent, M., & Powers, P. J. (1983) · Circulation · doi:10.1161/01.cir.67.4.901 · Cited by 218
Self-citationRandomized Prospective Trial of Continuous vs Intermittent Heparin Therapy
Glazier, R. L. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270130027021 · Cited by 205
Circadian changes in anticoagulant effect of heparin infused at a constant rate.
Decousus, H. A., Croze, M., Levi, F. A., Jaubert, J. G., Perpoint, B. M., De Bonadona, J. F., Reinberg, A., & Queneau, P. M. (1985) · BMJ · doi:10.1136/bmj.290.6465.341 · Cited by 182
DOYLE, D. J., TURPIE, A. G. G., HIRSH, J., BEST, C., KINCH, D., LEVINE, M. N., & GENT, M. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-441 · Cited by 171
Flier, J. S., Underhill, L. H., Wessler, S., & Gitel, S. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111007 · Cited by 138
Assessment of Anticoagulant Treatment of Venous Thromboembolism
Coon, W. W., Willis, P. W., & Symons, M. (1969) · Annals of Surgery · doi:10.1097/00000658-196910000-00007 · Cited by 137
Physician Practices in the Treatment of Pulmonary Embolism and Deep Venous Thrombosis
Wheeler, A. P. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380060085018 · Cited by 135
An objective study of alternative methods of heparin administration
Bentley, P. G., Kakkar, V. V., Scully, M. F., MacGREGOR, I. R., Webb, P. J., Chan, P. S., & Jones, N. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90182-6 · Cited by 126
Heparin kinetics: Variables related to disposition and dosage
Cipolle, R. J., Seifert, R. D., Neilan, B. A., Zaske, D. E., & Haus, E. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.53 · Cited by 126
Ofosu, F. A., Siè, P., Modi, G. J., Fernandez, F., Buchanan, M. R., Blajchman, M. A., Boneu, B., & Hirsh, J. (1987) · Biochemical Journal · doi:10.1042/bj2430579 · Cited by 123
Heparin therapy: A randomized prospective study
Wilson, J. R., & Lampman, J. H. (1979) · American Heart Journal · doi:10.1016/0002-8703(79)90349-1 · Cited by 116
Hemorrhagic Complications of Anticoagulant Therapy
Levine, M., & Hirsh, J. (1986) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1003533 · Cited by 108
Heparin Pharmacokinetics: Increased Requirements in Pulmonary Embolism
Simon, T. L., Hyers, T. M., Gaston, J. P., & Harker, L. A. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb07133.x · Cited by 96
Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., & Dettori, A. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647289 · Cited by 82
Audit of control of heparin treatment.
Fennerty, A. G., Thomas, P. S., Backhouse, G., Bentley, P. G., Campbell, I. A., & Routledge, P. (1985) · BMJ · doi:10.1136/bmj.290.6461.27-a · Cited by 75
HEPARIN DOSES AND MAJOR BLEEDINGS
Morabia, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91421-2 · Cited by 74
Walker, M. G., Shaw, J. W., Thomson, G. J. L., Cumming, J. G. R., & Thomas, M. (1987) · BMJ · doi:10.1136/bmj.294.6581.1189 · Cited by 47
Guidelines for the Management of Anticoagulant Therapy
Gurewich, V. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0028-1086123 · Cited by 12
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationHirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
Metadata
- Authors
- Hull, R. D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1992-08-01
- Volume
- 152
- Issue
- 8
- Pages
- 1589-1589
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2050424823
- Cited by
- 260
- References
- 39
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.